on behalf the Groupe Francophone des Myélodysplasies

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

L. Mannone, P. Fenaux, N. Vey, 2011, Annals of Hematology.